Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) has been given a consensus recommendation of “Hold” by the eight ratings firms that are covering the company, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price […]
Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) have been given an average rating of “Hold” by the eight brokerages that are covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price target […]
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) shares dropped 4.8% during mid-day trading on Monday . The stock traded as low as $2.50 and last traded at $2.80. Approximately 213,448 shares changed hands during mid-day trading, a decline of 6% from the average daily volume of 226,250 shares. The stock had previously closed at […]
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 52,300 shares, a decline of 24.0% from the November 15th total of 68,800 shares. Based on an average daily trading volume, of 122,900 […]
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) saw a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 23,700 shares, a decrease of 38.1% from the September 30th total of 38,300 shares. Based on an average daily volume of 85,000 shares, the days-to-cover ratio […]